Fat Burner

Un complément alimentaire naturel

 Fat Burner est idéal pour tonifier votre silhouette. 

Il est composé d'éléments actifs naturels :

Le CLA ou Acide Linoléique Conjugué, est un composé d'acides gras essentiels, naturellement présent dans les viandes et les laitages. Ce composé disparait peu à peu de notre alimentation en raison de l'alimentation de plus en plus industrialisée de ces animaux. Il faudrait ainsi manger près de 3 kg par jour de viande pour combler nos besoins en CLA, ce qui aurait des impacts négatifs sur le reste de notre organisme (surcharge en protéines, en graisses...). Cet acide gras essentiel permet de manger moins tout en conservant son tonus.

L'extrait de thé vert concentré. Le thé vert est utilisé par la population chinoise depuis de nombreux siècles. 

La réglementation Européenne nous interdit de communiquer sur ces produits. Si vous souhaitez en savoir plus, nous vous invitons à vous renseigner auprès de spécialistes.

Conseils d'utilisation de Fat Burner

Prendre 1 capsule avant chaque repas, soit 3 capsules par jour.

Il est conseillé d'utiliser Fat Burner en consommant sur une période longue, l'idéal est entre 10 et 12 semaines.

Ce complément alimentaire doit être consommé en parallèle d'une alimentation variée et équilibrée.

Composition du complément minceur Fat Burner

CLA (Acide Linoléique Conjugué), extrait de thé vert concentré (2000/1), polyphenon 60. Capsule en gélatine marine, glycérine et caroube. Sans colorant ni conservateur artificiel.

Valeur d'une prise journalière : Lipide : acide gras insaturé : CLA : 1500 mg, acide gras saturé : 150 mg, Hydrate de carbone (glucide) : 303 mg, Protide : 365,4 mg, Calories totales : 17,52 cal. Poids/capsule : 742,35 mg.

Bibliographie sur les éléments présents dans Fat Burner

Source : Passeportsante.net

Cette bibliographie ne constitue en rien une recommandation de notre part et vise uniquement à vous permettre de vous renseigner par vous-même.

1. FDA US Food and Drug Administration. Drugs – Development and Approval Process - NME Drug and New Biologic Approvals in 2006. [Consulté le 2 juin 2010]. https://www.fda.gov.

2. A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts. Gross G, Meyer KG, et al. J. Eur Acad Dermatol Venereol. 2007 Nov;21(10):1404-12.

3. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial. Stockfleth E, Beti H, et al. Br J Dermatol. 2008 Jun;158(6):1329-38. Epub 2008 Mar 20.

4. Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial. Tatti S, Swinehart JM, et al. Obstet Gynecol. 2008 Jun;111(6):1371-9.

5. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Hooper L, Kroon PA, et al. Am J Clin Nutr. 2008 Jul;88(1):38-50.

6. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Nagao T, Hase T, Tokimitsu I. Obesity (Silver Spring). 2007 Jun;15(6):1473-83.

7. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Hsu CH, Tsai TH, et al. Clin Nutr. 2008 Jun;27(3):363-70. Epub 2008 May 12.

8. Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Matsuyama T, Tanaka Y, et al. Obesity (Silver Spring). 2008 Jun;16(6):1338-48. Epub 2008 Mar 20.

9. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. Frank J, George TW, et al. J Nutr. 2009 Jan;139(1):58-62. Epub 2008 Dec 3.

10. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nantz MP, Rowe CA, et al. Nutrition. 2009 Feb;25(2):147-54. Epub 2008 Oct 9.

11. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Brown AL, Lane J, et al. Br J Nutr. 2009 Mar;101(6):886-94. Epub 2008 Aug 19.

12. Purified black tea theaflavins and theaflavins/catechin supplements did not affect serum lipids in healthy individuals with mildly to moderately elevated cholesterol concentrations. Trautwein EA, Du Y, et al. Eur J Nutr. 2010 Feb;49(1):27-35. Epub 2009 Jul 29.

13. Tea catechin consumption reduces circulating oxidized low-density lipoprotein. Inami S, Takano M,et al. Int Heart J. 2007 Nov;48(6):725-32.

17. FDA US Food and Drug Administration. Food – Labeling and Nutrition - Qualified Health Claims: Letter of Denial - Green Tea and Reduced Risk of Cardiovascular Disease (Docket No. 2005Q-0297). [Consulté le 2 juin 2010]. https://www.fda.gov.

18. Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Phung OJ, Baker WL, et al. Am J Clin Nutr. 2010 Jan;91(1):73-81. Epub 2009 Nov 11. Review.

19. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Dulloo AG, Duret C, et al. Am J Clin Nutr. 1999 Dec;70(6):1040-5.

20. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Westerterp-Plantenga MS, Lejeune MP, Kovacs EM. Obes Res. 2005 Jul;13(7):1195-204.

21. Effectiveness of green tea on weight reduction in obese Thais: A randomized, controlled trial. Auvichayapat P, Prapochanung M, et al. Physiol Behav. 2008 Feb 27;93(3):486-91. Epub 2007 Oct 18.

22. The epidemiology of prostatic cancer. Geographical distribution and time-trends. Muir CS, Nectoux J, Staszewski J. Acta Oncol. 1991;30(2):133-40. Review.

23. Global cancer statistics, 2002. Parkin DM, Bray F, et al. CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108.

24. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Yang CS, Wang X, et al. Nat Rev Cancer. 2009 Jun;9(6):429-39. Review.

26. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Kurahashi N, Sasazuki S, et al; JPHC Study Group. Am J Epidemiol. 2008 Jan 1;167(1):71-7. Epub 2007 Sep 29.

27. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Jian L, Xie LP, et al. Int J Cancer. 2004 Jan 1;108(1):130-5.

28. No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study. Kikuchi N, Ohmori K, et al. Br J Cancer. 2006 Aug 7;95(3):371-3. Epub 2006 Jun 27.

29. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Bettuzzi S, Brausi M, et al. Cancer Res. 2006 Jan 15;66(2):1234-40.

30. The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Seely D, Mills EJ, et al. Integr Cancer Ther. 2005 Jun;4(2):144-55. Review.

31. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Sun CL, Yuan JM, et al. Carcinogenesis. 2006 Jul;27(7):1310-5. Epub 2005 Nov 25.

32. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Ogunleye AA, Xue F, Michels KB. Breast Cancer Res Treat. 2010 Jan;119(2):477-84. Epub 2009 May 13. Review.

34. Reduced risk of esophageal cancer associated with green tea consumption. Gao YT, McLaughlin JK, et al. J Natl Cancer Inst. 1994 Jun 1;86(11):855-8.

35. Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Sun CL, Yuan JM, et al. Carcinogenesis. 2002 Sep;23(9):1497-503.

36. Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer. Wang LD, Zhou Q, et al. Gan To Kagaku Ryoho. 2002 Feb;29 Suppl 1:159-72.

42. Tea consumption and risk of endometrial cancer: a metaanalysis. Tang NP, Li H, et al. Am J Obstet Gynecol. 2009 Dec;201(6):605.e1-8. Epub 2009 Sep 20.

43. FDA US Food and Drug Administration. Food – Labeling and Nutrition - Letter Responding to Health Claim Petition dated January 27, 2004: Green Tea and Reduced Risk of Cancer Health Claim (Docket number 2004Q-0083) (Docket number 2004Q-0083). [Consulté le 2 juin 2010]. https://www.fda.gov.

44. Effect of cocoa and tea intake on blood pressure: a meta-analysis. Taubert D, Roesen R, Schömig E. Arch Intern Med. 2007 Apr 9;167(7):626-34.

51. Santé Canada. Médicaments et produits de santé – Extraits de thé vert. Gouvernement du Canada. [Consulté le 2 juin 2010]. https://www.hc-sc.gc.ca.

52. Santé Canada. Médicaments et produits de santé – Bulletin canadien des effets indésirables. Gouvernement du Canada. [Consulté le 2 juin 2010]. https://www.hc-sc.gc.ca.

53. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Lu K, Gray MA, Oliver C, Liley DT, Harrison BJ, Bartholomeusz CF, Phan KL, Nathan PJ. Hum Psychopharmacol. 2004 Oct;19(7):457-65.

54. L-theanine, a natural constituent in tea, and its effect on mental state. Nobre AC, Rao A, Owen GN. Asia Pac J Clin Nutr. 2008;17 Suppl 1:167-8.

55. L-Theanine reduces psychological and physiological stress responses. Kimura K, Ozeki M, Juneja LR, Ohira H. Biol Psychol. 2007 Jan;74(1):39-45.

56. Specific formulation of Camellia sinensis prevents cold and flu symptoms and enhances gamma,delta T cell function: a randomized, double-blind, placebo-controlled study. Rowe CA, Nantz MP, et al. J Am Coll.Nutr 2007;26(5):445-452.

1. Conjugated linoleic acids: why the discrepancy between animal and human studies? Plourde M, Jew S, et al. Nutr Rev. 2008 Jul; 66(7):415-21. Review.

2. Conjugated linoleic acid (CLA) and obesity. Silveira MB, Carraro R, et al. Public Health Nutr. 2007 Oct; 10(10A):1181-6. Review.

3. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Whigham LD, Watras AC, Schoeller DA. Am J Clin Nutr. 2007; 85:1203-1211.

4. Conjugated linoleic acids. Campbell B, Kreider RB. Curr Sports Med Rep. 2008 Jul-Aug; 7(4):237-41. Review.

5. Conjugated linoleic acid (CLA): effect modulation of body composition and lipid profile. Baddini Feitoza A, Fernandes Pereira A, et al. Nutr Hosp. 2009 Jul-Aug; 24(4):422-8. Review.

6. A meta-analysis of the effects of conjugated linoleic acid on fat-free mass in humans. Schoeller DA, Watras AC, Whigham LD. Appl Physiol Nutr Metab. 2009 Oct; 34(5):975-8.

7. Effects of milk supplementation with conjugated linoleic acid (isomers cis-9, trans-11 and trans-10, cis-12) on body composition and metabolic syndrome components. Laso N, Brugue E, et al. Br J Nutr. 2007 Oct; 98(4):860-7.

8. Effect of a conjugated linoleic acid and omega-3 fatty acid mixture on body composition and adiponectin. Sneddon AA, Tsofliou F, et al. Obesity (Silver Spring). 2008 May; 16(5):1019-24.11.

9. Kelly GS. Conjugated linoleic acid: a review.Altern Med Rev 2001 Aug; 6(4):367-82. Texte intégral : https://www.thorne.com

10. Ryder JW, Portocarrero CP, Song XM, et al. Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression.Diabetes 2001 May; 50(5):1149-57.

11. Zambell KL, Horn WF, Keim NL. Conjugated linoleic acid supplementation in humans: effects on fatty acid and glycerol kinetics.Lipids2001 Aug; 36(8):767-72.

12. Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans--metabolic effects.Lipids 2001 Aug; 36(8):773-81.Review.

13. Noone EJ, Roche HM, et al. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects.Br J Nutr 2002 Sep; 88(3):243-51.

14. The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese. Syvertsen C, Halse J, et al. Int J Obes (Lond). 2007 Jul; 31(7):1148-54.

15. Moloney F, Yeow TP, et al. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2004 Oct; 80(4):887-95.

16. Effects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin secretion and estimated insulin sensitivity in men. Ahrén B, Mari A, et al. Eur J Clin Nutr. 2009 Jun; 63(6):778-86.

17. Riserus U, Basu S, et al. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation. 2002 Oct 8; 106(15):1925-9.

18. Riserus U, Arner P, et al. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care. 2002 Sep; 25(9):1516-21.

19. Riserus U, Vessby B, et al. Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia. 2004 Jun; 47(6):1016-9.

20. Riserus U, Vessby B, et al. Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr. 2004 Aug; 80(2):279-83.

21. Conjugated linoleic acid combined with creatine monohydrate and whey protein supplementation during strength training. Cornish SM, Candow DG, et al. Int J Sport Nutr Exerc Metab. 2009 Feb; 19(1):79-96.

22. The potential benefits of creatine and conjugated linoleic acid as adjuncts to resistance training in older adults. Tarnopolsky MA, Safdar A. Appl Physiol Nutr Metab. 2008 Feb; 33(1):213-27. Review.

23. Desroches S, Chouinard PY, et al. Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the lipid profile and body composition of overweight and obese men. Am J Clin Nutr. 2005 Aug; 82(2):309-19.

24. Gaullier JM, Halse J, et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans.Am J Clin Nutr. 2004 Jun; 79(6):1118-25. Texte intégral : https://www.ajcn.org

25. Dietary supplementation with cis-9,trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults. Sluijs I, Plantinga Y, et al. Am J Clin Nutr. 2010 Jan; 91(1):175-83.

26. O’Shea M, Bassaganya-Riera J, Mohede IC. Immunomodulatory properties of conjugated linoleic acid. Am J Clin Nutr. 2004 Jun; 79(6 Suppl):1199S-1206S. Texte integral : https://www.ajcn.org

27. Kelley DS, Erickson KL. Modulation of body composition and immune cell functions by conjugated linoleic acid in humans and animal models: benefits vs. risks. Lipids. 2003 Apr; 38(4):377-86. Review.

28. Albers R, van der Wielen RP, et al. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. Eur J Clin Nutr. 2003 Apr; 57(4):595-603.

29. Nugent AP, Roche HM, et al. The effects of conjugated linoleic acid supplementation on immune function in healthy volunteers. Eur J Clin Nutr. 2005 Jun; 59(6):742-50.

30. Song HJ, Grant I, et al. Effect of CLA supplementation on immune function in young healthy volunteers. Eur J Clin Nutr. 2005 Apr; 59(4):508-17.

31. Tricon S, Burdge GC, et al. Effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on immune cell function in healthy humans. Am J Clin Nutr. 2004 Dec; 80(6):1626-33. Texte intégral : http:https://www.ajcn.org

32. Immunological and metabolic effects of cis-9, trans-11-conjugated linoleic acid in subjects with birch pollen allergy. Turpeinen AM, Ylonen N, et al.Br J Nutr. 2008 Jul;100(1):112-9.29.

33. Masters N, McGuire MA, et al. Maternal supplementation with CLA decreases milk fat in humans.Lipids 2002 Feb; 37(2):133-8.

34. Taylor JS, Williams SR, et al. Conjugated linoleic acid impairs endothelial function. Arterioscler Thromb Vasc Biol. 2006 Feb; 26(2):307-1.

35. ConsumerLab.com. Product Review: CLA (Conjugated Linoleic Acid) for Slimming, janvier 2010 [Consulté le 27 février 2010] https://www.consumerlab.com